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 Abstract 
 
Objectives: 
The urothelium and lamina propria play important roles in the maintenance of normal bladder function.  
Recently, contraction has been added to the properties the tissue possesses, but little is known about the 
mechanisms regulating this activity. This study examines the actions of 5-HT (serotonin) on the 
contractile properties of the urothelium and lamina propria, since a better understanding of bladder 
physiology may aid the development of new treatments. 
Methods: 
Strips of porcine urothelium and lamina propria were suspended in gassed Krebs-bicarbonate solution 
and cumulative concentration-response curves to 5-HT were generated in the absence and presence of 
5-HT antagonists, L-NNA and indomethacin. Responses to α-methyl-5-hydroxytryptamine were also 
examined. 
Results: 
Strips of urothelium/lamina propria developed spontaneous contractions, while the addition of 5-HT 
induced concentration-dependent increases in contractile tone with maximal contractions of 50.43 ± 
2.78mN per gram tissue weight (n=100). Tonic contractions to 5-HT were unchanged in the presence 
of L-NNA (100µM) or indomethacin (5µM). Selective concentrations of the antagonists methiothepin 
(5-HT1&2, 100nM), RS102221 (5-HT2C, 30nM), ondansetron (5-HT3, 30nM), GR113808, (5-HT4, 
100nM), SB699551 (5-HT5, 10nM), SB399885 (5-HT6, 100nM), SB269970 (5-HT7, 10nM) did not 
influence responses to 5-HT. However, the 5-HT2A antagonist ketanserin (30-300µM) caused a shift of 
the 5-HT curve yielding an affinity estimate of 7.9. 
Conclusions: 
The results indicate that contractile responses of the urothelium/lamina propria to 5-HT are 
predominantly mediated via the 5-HT2A receptor. 
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 Introduction: 
Bladder dysfunction is a common urological condition, yet the underlying mechanisms involved in 
maintaining normal continence are still not fully understood. Whilst the detrusor is the main muscle 
responsible for bladder contraction and micturition, the urothelium and lamina propria (urothelium/LP) 
is now recognised as a responsive tissue that performs important functions detecting a range of 
mechanical and chemical stimuli and transducing these signals to closely located afferent nerves, 
myofibroblasts and smooth muscle.1 A range of receptors are located on the urothelium, including P2X 
and P2Y receptors2, muscarinic, nicotinic3, α and β adrenergic receptors4 and oestrogen receptors5. In 
recent years another property of the urothelium/LP has been recognised, where the urothelium/LP 
develops both phasic and tonic contractile activity, with spontaneous contractions developing in isolated 
strips of urothelium/LP in the absence of any external stimulation.6 Tonic contractions can be stimulated 
in isolated tissues through a range of receptors including muscarinic M3,6 tachykinin NK2,7 and 
adrenergic alpha1-adrenoceptors,4 whilst nitric oxide8 and beta-adrenoceptor4 stimulation inhibit 
contractile activity. Physiologically, this activity could serve several purposes, including a role in 
folding of the urothelium when the bladder is empty, maintaining neuronal afferent sensitivity, or 
mediating the spontaneous contractile activity of the detrusor in disease.9, 10 
 
5-Hydroxytryptamine (5-HT) is a monoamine neurotransmitter that has a range of roles throughout the 
body, including regulation of bowel motility, neurological processes and cardiovascular function.11  In 
the lower urinary tract 5-HT exerts a number of effects. These include enhancement of acetylcholine 
release from parasympathetic nerves via pre-junctional 5-HT4 receptors in the pig12 and human 
bladder,13 and relaxation of the urethra of the pig via 5-HT7 receptors.14 There is indirect evidence 
suggesting 5-HT endogenous synthesis and release in the rat urinary bladder15, and it has been suggested 
that 5-HT is also released from mast cells infiltrating the lamina propria.16 The expression of 5-HT2A, 
5-HT2B, 5-HT3A, 5-HT4 and 5-HT7 have been identified in both the urothelium and detrusor of patients 
with normal functioning bladders, and also patients with benign prostatic hyperplasia using Real-Time 
Reverse Transcription Polymerase Chain Reaction.17 This study also identified the presence of 5-HT2B 
and 5-HT7 receptors in these patients using Immunohistochemistry.17 However, no studies have ever 
examined the influence of 5-HT on urothelial contractile activity. The aim of the present study was to 
examine the effects of 5-HT on the contractile properties of the porcine urothelium/LP and identify the 
predominant receptor subtype responsible for mediating these responses. 
 
Methods 
Functional Organ Bath Studies 
Fresh bladders from large White-Landrace pigs (aged 6 months, weight ∼80 kg) were obtained from a 
local abattoir and immediately immersed in cold Krebs-bicarbonate solution (NaCl 118.4 mM, NaHCO3 
24.9 mM, CaCl2 1.9 mM, MgSO4 2.41 mM, KCl 4.6 mM, KH2PO4 1.18 mM and D-glucose 11.7 mM). 
The bladders were opened longitudinally, and full-thickness strips of the anterior wall from the dome 
region were removed. From these tissues, strips of urothelium with lamina propria were prepared (20 × 
5 mm) and immersed in Krebs-bicarbonate solution in 10mL organs baths (Labglass, Brisbane, 
Australia) maintained at 37°C and gassed with 5% carbon dioxide in oxygen. The tissues were attached 
to isometric force transducers (MCT050/D, ADInstruments, Castle Hill, Australia), and tensions 
recorded with a Powerlab system using Labchart, version 7, software (ADInstruments). After washing 
with fresh Krebs solution, the tissues were allowed to equilibrate for 45 minutes before starting the 
addition of drugs. For studies with the antagonists, adjacent pieces of tissue were dissected, set up in 
pairs under identical conditions, and allowed to equilibrate. One tissue was incubated with the 
antagonist for 20 minutes, and the other was used as a control in the absence of any antagonist. 
 Concentrations of antagonist that would be selective for particular receptor subtypes were carefully 
determined using affinity values appearing in the literature. 
 
Measurements of the frequency and baseline tension were taken at the peak response after the addition 
of each agonist. The frequency of contractions was expressed as the number of phasic waves per minute 
(cycles/min) and the baseline tension as Newton force per gram tissue weight (average tissue weight: 
0.25 ± 0.004g). The baseline tension was taken as the lowest point of the spontaneous phasic 
contractions. Concentration-response curves were analysed using Graphpad Prism (v6) software 
(GraphPad, San Diego, CA). Mean (± sem) pEC50 values obtained in the absence and presence of 
antagonists were compared using a Student’s 2-tailed paired t-test, with P <.05 considered statistically 
significant. For ketanserin, where a range of concentrations were examined, a one-way analysis of 
variance (ANOVA) with a Dunnett’s test was used to compare pEC50 values. 
 
Drugs, Chemical Reagents and Other Materials 
Serotonin hydrochloride was obtained from Toronto Research Chemicals Inc. (Toronto, Canada), 
methiothepin mesylate, N-nitro-L-arginine (L-NNA), indomethacin, carbamoylcholine (carbachol), 
dimethyl sulfoxide (DMSO) and ketanserin (+)-tartrate salt from Sigma-Aldrich (St Louis, Missouri, 
USA), ondansetron hydrochloride from Selleckchem (Houston, TX, USA), GR113808, RS102221, 
SB699551, SB399885 and SB269970 from Tocris (Ellisville, Missouri, USA) and α-methyl 5-HT 
maleate (α-Me-5-HT) from Abcam Inc. (Cambridge, MA, USA). Concentrations of antagonists were 
selected based on their relative affinities at each receptor subtype as published in the literature. A 
maximum concentration for a selective action was chosen that did not exert affects at the other 5-HT 
receptor subtypes. The concentrations of L-NNA and indomethacin were selected based on those used 
in the vast majority of published studies and confirmed in previous experiments in our laboratory.  The 
concentrations of indomethacin and L-NNA were approximately 100-fold greater than their IC50 value 
for inhibition of COX and NOS respectively.18, 19 
 
Results 
Strips of urothelium/LP developed spontaneous phasic contractions that occurred at a frequency of 
3.49±0.08 cycles/min and an amplitude of 12.7±9.53mN per gram tissue weight (n=100). Cumulative 
additions of 5-HT induced large concentration-dependent tonic contractions of the tissue with a pEC50 
of 5.36±0.16 and maximum contractile responses of 50.43±2.78mN per gram tissue weight (n = 100, 
Figure 1).  Simultaneously, 5-HT also produced small increases in the frequency and amplitude of the 
spontaneous contractions, the frequency increasing by 26.36% (P<0.001) and the amplitude by 21.88% 
(P<0.001) during the course of a full concentration-response curve. Neither tonic contraction nor 
spontaneous phasic contractile activity were affected by the presence of either the nitric oxide synthesis 
inhibitor, L-NNA (100µM, n=7) or the cyclooxygenase inhibitor, indomethacin (5µM, n=7, Figure 2).  
 
Influence of selective 5-HT receptor antagonists 
Concentrations of 5-HT antagonists were chosen that would have selective actions on specific receptor 
subtypes and their effects on urothelium/LP responses to 5-HT investigated. Neither methiothepin (5-
HT1&2, 100nM, n=10), RS102221 (5-HT2C, 30nM, n=8), ondansetron (5-HT3, 30nM, n=8), GR113808, 
(5-HT4, 100nM, n=8), SB699551 (5-HT5, 10nM, n=8), SB399885 (5-HT6, 100nM, n=11) nor 
SB269970 (5-HT7, 10nM, n=8) had any effect on either the tonic contractions induced by 5-HT (Figure 
3), or the maximum contractile responses (Table 1).  However, the 5-HT2A receptor antagonist 
ketanserin caused a shift of 5-HT concentration-response curves to the right, yielding an affinity 
estimate of 7.9 (100nM, n=13). This shift of the concentration-response curve was greater than the shift 
 observed at 30nM (affinity estimate also 7.9, n=4), but increasing the concentration to 300nM (n=6) 
had no additional effect (Figure 4). 
 
 
 
 
 
Figure 1. Experimental trace showing the 
responses of isolated U&LP strips to increasing 
concentrations of 5-HT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Mean (± SEM) cumulative 
concentration-response curves of 
urothelial/LP strips to 5-HT in the 
absence and presence of [A] 
indomethacin (5µM, n=7) and [B] L-
NNA (100µM, n=7). Responses are 
plotted as a percentage of the 
maximum contraction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 1. Calculated pEC50 and maximum contraction values to 5-HT in the presence and absence of 
5-HT receptor antagonists. **p<0.01. 
 
Antagonist nM N pEC50 Maximum contraction (mN/g) 
 
  
Control Antagonist Control Antagonist 
Methiothepin 100 10 5.17 ± 0.27 5.45 ± 0.39 56.38 ± 7.54 49.63 ± 7.94 
Ketanserin 100 13 5.62 ± 0.39     4.31 ± 0.22** 34.94 ± 5.96  50.03 ± 7.15 
RS102221 30 8 5.37 ± 0.29  5.07 ± 0.25  54.00 ± 7.94  41.30 ± 6.35 
Ondansetron 30 8 5.49 ± 0.47 5.15 ± 0.25 42.49 ± 8.34  47.65 ± 6.75 
GR113808 100 8 4.98 ± 0.20 5.29 ± 0.26  43.28 ± 5.56 43.68 ± 5.16 
SB699551 10 8 5.44 ± 0.47 5.25 ± 0.57 32.56 ± 7.54 33.75 ± 7.94 
SB399885 100 11 5.54 ± 0.29 5.54 ± 0.44 59.96 ± 9.93 54.41 ± 10.32 
SB269970 10 8 5.38 ± 0.38 5.19 ± 0.36 42.88 ± 8.34 47.25 ± 8.34 
 
  
Figure 3. Mean (± SEM) cumulative 5-HT concentration-response curves in the absence and presence 
of 5-HT antagonists (n=>8).  Responses are expressed as a percentage of the maximum response for 
each curve. 
 
 
 
  
Figure 4. 5-HT concentration-response curves in the presence of 30nM (n = 4), 100nM (n = 13) and 
300nM (n = 6) ketanserin. 
 
 
 
Responses to α-methyl-5-HT  
Concentration-response curves were also obtained to the 5-HT2-selective agonist α-Me-5-HT.  This 
agonist produced concentration-dependent contractions of the isolated urothelium/LP (n = 8) with a 
mean maximum response similar to that of 5-HT (Figure 5), but had a slightly lower potency with a 
pEC50 of 4.94±0.09 (P<0.01). Ketanserin (100nM) did not significantly affect maximum responses, 
but produced shifts of the α-Me-5-HT concentration-response curves similar to those observed using 5-
HT as the agonist, reducing the pEC50 value of α-Me-5-HT to 4.01 ± 0.07 (n = 4, P = 0.005). 
 
  
Figure 5. [A] Cumulative concentration-response curves to 5-HT and α-methyl-5-HT in porcine 
urothelium/LP (n = 8).  [B] Cumulative concentration-response curves to α-Methyl-5-HT in the 
absence and presence of ketanserin (100nM, n = 4). Responses are plotted as a percentage of the 
maximum response. 
  
 
 
Discussion 
The urothelium/LP was once thought to function solely as a protective barrier between urine and the 
detrusor smooth muscle.  However, over the years it has been shown to release a number of mediators, 
including acetylcholine, when stretched.6  More recently, contraction of the urothelium/LP has been 
established in several studies, with the tissue responding to a range of stimuli including neurokinin-A, 
carbachol and electrical field stimulation.7, 10  The tissue also possesses adrenoceptors that regulate 
contractile activity: alpha1-adrenoceptors enhance activity, while beta-adrenoceptors cause inhibition.4  
Nitric oxide donors have also been reported to inhibit contractions of this tissue.8  The present study 
has investigated the influence of 5-HT on urothelial/LP contractile activity and demonstrated tonic 
contractile responses and increases in phasic activity.    
 
Nitric oxide (NO) and prostaglandins are known modulators of bladder activity. NO can be released 
from the urothelium in some situations such as during inflammation20 and NO donors have been shown 
to influence the contractile activity of the urothelium and detrusor.8, 21 However, responses of the 
urothelium/LP were not affected by the NO synthase inhibitor L-NNA indicating a lack of involvement 
of NO in the 5-HT responses.  Prostaglandins are also released from the urothelium/LP 22 and their main 
role is thought to be an influence on sensory nerve activity23. A role for prostaglandins in detrusor 
overactivity has been suggested in the rat24, 25, where inhibition of prostaglandin synthesis can reduce 
bladder spontaneous activity and reduce detrusor overactivity. It is well established that prostaglandins 
can influence smooth muscle contraction, but they were not involved in the urothelium/LP contractile 
activity in the present study since indomethacin had no effect on the responses to 5-HT. 
 
Of the 5-HT antagonists examined in this study, only ketanserin influenced responses of the 
urothelium/LP to 5-HT.  This drug is a selective 5-HT2A receptor antagonist at the concentrations used. 
At 30nM and 100nM ketanserin produced parallel rightward shifts of the 5-HT concentration-response 
curve without any change in maximum responses suggesting a competitive mode of action.  However, 
the highest concentration of ketanserin (300nM) failed to induce any further shift of the curve, 
suggesting the involvement of a second receptor at higher concentrations of 5-HT, as would be 
expected. Affinity values for ketanserin at 5-HT2A receptors appearing in the literature26, 27 commonly 
vary between 8.1 – 8.6, which is consistent with the values determined in this study. A role for 5-HT2A 
receptors is supported by the data with α-Me-5-HT, a drug that has been used widely used as a selective 
5-HT2 receptor agonist.28 This drug was a potent agonist producing contractions similar in magnitude 
to those with 5-HT and the shifts in concentration-response curves induced by ketanserin were similar 
for both agonists.  This suggested both drugs act predominantly via the same 5-HT2A receptor subtype. 
 
The results illustrate the complex nature of lower urinary tract responses to 5-HT.  5-HT4 receptors are 
located pre-junctionally on parasympathetic nerves in the detrusor where they regulate neurotransmitter 
release, 5-HT7 receptors relax muscle tone in the bladder outlet region, while neurogenic contractions 
of the detrusor muscle appear to be via both 5-HT7 and 5-HT2.29  The receptor subtype mediating muscle 
contraction on the porcine detrusor has yet to be established, but the present study has now identified 
the predominant receptor regulating urothelial/LP tone as the 5-HT2A receptor subtype. 
 
The physiological significance of contractile activity within the urothelium/LP is not clear.  It may act 
to sensitize afferent nerves to maintain afferent activity that may otherwise adapt to stretch, or it may 
function to form folds of the urothelium when the bladder is empty.  It has also been suggested that this 
 contractile activity may drive detrusor contraction during bladder overactivity,6 an effect that would 
evolve from the increase in gap junctions identified in the overactive bladder.30  The role played by 5-
HT in bladder physiology and pathology is also unknown, but the present study has identified the 
presence of functional 5-HT receptors in the urothelium/LP and if 5-HT is released in disease, these 
may represent a target for drug development to influence bladder activity. 
 
In conclusion, this study has identified the presence of 5-HT in the bladder urothelium/LP that influence 
contractile activity.  The predominant receptor appears to be the 5-HT2A receptor subtype and this 
receptor may represent a therapeutic target for the development of pharmacological treatments of 
diseases related to bladder contractile activity, such as overactive bladder. 
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